AGAP9
Chr 10ArfGAP with GTPase domain, ankyrin repeat and PH domain 9
Also known as: AGAP-9, CTGLF6, bA301J7.2
The AGAP9 protein functions as a GTPase-activating protein that regulates GTPase activity. Mutations in AGAP9 cause autosomal recessive intellectual disability with developmental delay. The inheritance pattern is autosomal recessive.
Population Genetics & Constraint
Constraint data not available from gnomAD.
The highest-scoring mechanism for this gene is dominant-negative.
Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.
Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.
ClinVar Variant Classifications
113 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories· variant type breakdown unavailable
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | — | — | — | — | 33 |
Likely Pathogenic | — | — | — | — | 16 |
VUS | — | — | — | — | 20 |
Likely Benign | — | — | — | — | 4 |
Benign | — | — | — | — | 39 |
| Total | — | 112 | |||
Counts from ClinVar esearch · Updated hourly
View in ClinVar →Protein Context — Lollipop Plot
AGAP9 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
No active trials found for this gene.
Search ClinicalTrials.gov →No open access results found
External Resources
Links to major genomics databases and tools